ChristopherYParkMD

Pathology • New York, NY

Hematopathology, Anatomic Pathology

Physician

Join to view full profile

Dr. Park is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Park's full profile

Already have an account?

Office
1275 York Ave
New York, NY 10065
Phone+1 212-639-2000

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematopathology, 2003 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2002

Certifications & Licensure

CA State Medical License 2003 - Present
NY State Medical License 2009 - 2025
American Board of Pathology Anatomic Pathology
American Board of Pathology Hematology

Publications & Presentations

PubMed

DOGMA-seq and multimodal, single-cell analysis in acute myeloid leukemia.
JangKeun Kim, Nathan Schanzer, Ruth Subhash Singh, Mohammed I Zaman, J Sebastian Garcia-Medina
International Review of Cell and Molecular Biology. 2025-01-01
1 citations
BRAF V600E mutation and high expression of PD-L1 in Rosai-Dorfman disease: case report and review of the literature.
Farnoush M Moen, Mariam M Youssef, Mihir Shukla, Mary Lynn Nierodzik, Marius E Mayerhoefer
Journal of Hematopathology. 2024-12-01
Spatial and Single Cell Mapping of Castleman Disease Reveals Key Stromal Cell Types and Cytokine Pathways.
David Smith, Anna Eichinger, Andrew Rech, Julia Wang, Eduardo Esteva
Biorxiv. 2024-09-09

Abstracts/Posters

Unique Regulatory Pathways Dictate the Translational Program in Hematopoietic Stem and Progenitor Cells
Christopher Y. Park, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Identification of Old HSCs with Preserved Self-Renewal and Long-Term Reconstitution Potential
Christopher Y. Park, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Mir-29 Maintains the Acute Myeloid Leukemia Epigenome By Regulating CBX2
Christopher Y. Park, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Targeting Disease Stem Cells in AML, MDSJanuary 31st, 2017

Grant Support

Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2021–2026
Translational Control of Leukemia Stem Cells - Resubmission - 1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Clinical and Molecular Heterogeneity in the Myelodysplastic SyndromesNEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Translational Control of Leukemia Stem Cells - Resubmission - 1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025
Translational Control of Leukemia Stem Cells - Resubmission - 1NEW YORK UNIVERSITY SCHOOL OF MEDICINE2020–2025